HIGHER: Seattle Genetics (SGEN), up 10% after announcing the HER2CLIMB trial met the primary endpoint of progression-free survival, showing that the addition of tucatinib was superior to trastuzumab and capecitabine alone, with a 46% reduction in the risk of disease progression or death … Foamix (FOMX), up 4% after announcing the FDA has approved its novel Amzeeq topical foam… HP Enterprise (HPE), up 3% after BofA Merrill Lynch analyst Wamsi Mohan upgraded the stock two notches to Buy from Underperform with a $19 price target, saying the company’s underlying trends are improving. The analyst cites the company’s improved free cash flows, the focus of the management on more stable growth, and continued capital returns… Yandex (YNDX), up 9% after reports claim that the Russian government is now considering placing a 50%-minus-one cap on the number of shares that can be held by non-Russian investors in strategically important tech firms, which is higher than the 20% limit proposed in a draft bill this summer, according to The Moscow Times. LOWER: AmerisourceBergen (ABC), McKesson (MCK), Cardinal Health (CAH) and Teva (TEVA) down in a range of 1% to 4% after the Washington Post reported the companies will pay $260M to settle with two Ohio counties in order to avoid a trial attempting to blame the companies for fueling the opioid crisis… Smith & Nephew (SNN), down 8% after announcing Namal Nawana will step down from the board and his position as CEO… Micro Focus (MFGP), down 11% after OpenText (OTEX) confirmed that it is not considering a potential acquisition of the company, disputing a report from last Friday.
previous post